PHAT
Phathom Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager):
Halterbreite -30.0% ·
Aktienfluss +9.3% ·
neue Nettopositionen -20.0%
— Formel
Konzentrierte Akkumulation — steigende Anteile bei weniger Haltern
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q2 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 70 | +3 | 31.41M | $340.87M | +8 | −5 |
| Q1 2026 | 70 | +3 | 28.31M | $314.61M | +9 | −6 |
| Q4 2025 | 67 | +2 | 22.91M | $380.11M | +2 | — |
| Q3 2025 | 13 | +2 | 15.27M | $179.73M | +2 | — |
| Q2 2025 | 8 | -4 | 10.36M | $99.34M | — | −4 |
| Q1 2025 | 9 | 0 | 3.37M | $21.12M | — | — |
| Q4 2024 | 9 | 0 | 2.95M | $23.99M | +2 | −2 |
| Q3 2024 | 8 | +2 | 2.05M | $37.04M | +3 | −1 |
| Q2 2024 | 6 | — | 1.55M | $15.95M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passiv) | 3.32M | — | $31.79M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (passiv) | 3.32M | — | $31.79M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (passiv) | 3.32M | — | $31.79M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passiv) | 3.32M | — | $31.79M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passiv) | 3.32M | — | $31.79M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passiv) | 3.32M | — | $31.79M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passiv) | 3.32M | — | $31.79M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passiv) | 3.32M | — | $31.79M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | The Vanguard Group ✦ (passiv) | 2.79M | — | $26.73M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | The Vanguard Group ✦ (passiv) | 2.79M | — | $26.73M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | The Vanguard Group ✦ (passiv) | 2.79M | — | $26.73M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Millennium Management ✦ | 2.25M | +330.0% | $21.58M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 13 | Geode Capital Management ✦ (passiv) | 1.07M | +5.3% | $10.26M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 14 | Geode Capital Management ✦ (passiv) | 1.07M | +5.3% | $10.26M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 15 | State Street Global Advisors ✦ (passiv) | 849.42K | -5.8% | $8.15M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 49.92K | -53.5% | $478,771 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 49.92K | -53.5% | $478,771 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 49.92K | -53.5% | $478,771 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | T. Rowe Price ✦ | 30.10K | +11.4% | $289,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 20 | Fidelity (FMR) ✦ | 5.88K | — | $56,399 | 0.0% | n/c | 1 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Keine neu erfassten Käufer in diesem Quartal. |
Ausgestiegen
| Marshall Wace | $1.97M | war 0.0% |
| Wellington Management | $1.26M | war 0.0% |
| Citadel Advisors | $1.13M | war 0.0% |
| Two Sigma Investments | $610,240 | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 173 Inhaber, 68.60M Anteile, $741.84M gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.